Nephros Inc. (NASDAQ:NEPH) Stock Short Interest Declines 45.5%

Nephros Inc. (NASDAQ:NEPH) was the recipient of a significant decrease in short interest during the month of September. As of September 30th, there was short interest totaling 25,302 shares, a decrease of 45.5% from the September 15th total of 46,400 shares. Currently, 0.2% of the company’s shares are sold short. Based on an average daily volume of 18,272 shares, the days-to-cover ratio is presently 1.4 days.

Hedge Funds Weigh In On Nephros

A number of hedge funds have recently made changes to their positions in NEPH. Cornerstone Capital Inc. purchased a new stake in Nephros during the 2nd quarter worth $459,000. BlackRock Inc. acquired a new stake in Nephros in the 2nd quarter valued at $67,000. Navellier & Associates Inc. raised its position in Nephros by 179.6% in the second quarter. Navellier & Associates Inc. now owns 53,479 shares of the company’s stock valued at $191,000 after purchasing an additional 34,353 shares during the period. De Lisle Partners LLP purchased a new position in Nephros in the second quarter valued at about $62,000. Finally, Bard Associates Inc. purchased a new position in Nephros in the second quarter valued at about $421,000. Hedge funds and other institutional investors own 41.10% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the company. Zacks Research raised Nephros to a “hold” rating in a research note on Monday, July 20th. Weiss Ratings raised shares of Nephros from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday, August 3rd. Benchmark reiterated a “speculative buy” rating on shares of Nephros in a report on Tuesday, August 18th. Finally, Northland Securities assumed coverage on shares of Nephros in a report on Friday, July 17th. They set a “market perform” rating and a $4.00 price objective on the stock. One analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $4.00.

Nephros Trading Down 0.4%

Shares of Nephros stock traded down $0.01 during trading hours on Thursday, reaching $3.50. The stock had a trading volume of 8,005 shares, compared to its average volume of 32,357. The firm has a market capitalization of $38.06 million, a price-to-earnings ratio of 21.90 and a beta of 1.64. Nephros has a 1 year low of $2.66 and a 1 year high of $6.42. The firm has a 50 day simple moving average of $4.11 and a two-hundred day simple moving average of $3.60.

Nephros (NASDAQ:NEPH) last issued its earnings results on Thursday, August 6th. The company reported $0.06 earnings per share (EPS) for the quarter. Nephros had a return on equity of 10.60% and a net margin of 8.38%. The business had revenue of $6.02 million during the quarter, compared to analysts’ expectations of $4.99 million. Sell-side analysts forecast that Nephros will post 0.15 EPS for the current year.

Nephros Company Profile

Nephros, Inc is a medical device company that develops and sells filtration products for healthcare and commercial applications. Its primary focus is point-of-use water filtration systems designed to help reduce bacteria, including waterborne pathogens such as Legionella, in hospitals, long-term care facilities, and other healthcare settings.

The company’s product portfolio includes disposable and durable water filtration systems intended for use at sinks, showers, and other water outlets.